Educational and Cultural Engagement and Incidence of Health Adverse Events

September 16, 2024 updated by: Olivier Beauchet, Jewish General Hospital

Educational and Cultural Engagement and Incidence of Health Adverse Events: Results From the Canadian Longitudinal Study on Aging

This study evaluated if the social and cultural activities decrease the incidence of dementia and frailty conditions.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

The past decade has been characterized by the involvement of Museums in individual health prevention and promotion by using art-based activities to improve quality of life and well-being. Visiting museum or over cultural and educational activity could be used for health prevention and promotion. For the development of appropriate educational and cultural activities, there is a need, first, to improve knowledge about social and health condition of older adult, and second to examine the effects of engagement in educational and social activity on incidence of health adverse events.

Study Type

Observational

Enrollment (Estimated)

30000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montréal, Quebec, Canada, H3T 1E2
        • Jewish General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

People from Canada who participate in the Canadian Longitudinal Study on Aging. Participants who have the habits to go to museums for art classes, workshops, guided visits, and others arts activities. Participants of Canadian Longitudinal Study on Aging who are involved in art and educational activities in their communities.

Description

Inclusion Criteria:

  • Being 50 years and over
  • Being enrolled in the Canadian Longitudinal Study on Aging
  • Actively involved in social and cultural activities

Exclusion Criteria:

  • Never enrolled in the Canadian Longitudinal Study on Aging
  • Less than 50 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression
Time Frame: around 20 years
It will be used the Depression scale which has a score of 10 or less. Each participant will be asses based on this scale. The depression scale evaluates the depression symptoms for a time period.
around 20 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motoric cognitive risk syndrome
Time Frame: around 20 years
Motoric cognitive risk syndrome represents a pre-dementia syndrome characterized by cognitive complaints and a slow gait speed.
around 20 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Olivier Beauchet, MD, Jewish General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 31, 2020

Primary Completion (Estimated)

May 31, 2025

Study Completion (Estimated)

July 31, 2025

Study Registration Dates

First Submitted

June 13, 2019

First Submitted That Met QC Criteria

June 13, 2019

First Posted (Actual)

June 17, 2019

Study Record Updates

Last Update Posted (Actual)

September 19, 2024

Last Update Submitted That Met QC Criteria

September 16, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2020-1842

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Observational

Subscribe